| 标题 |
 US Food and Drug Administration Approval Summary: Capivasertib With Fulvestrant for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast Cancer With PIK3CA/ AKT1/ PTEN Alterations 美国食品药品监督管理局批准摘要：Capivasertib联合氟维司群治疗激素受体阳性、人表皮生长因子受体2阴性伴PIK3CA/AKT1/PTEN改变的局部晚期或转移性乳腺癌
|
| 网址 | |
| DOI | |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
MMMMM
null
Virtual
caigou
GingerF
CAOHOU
不配.
XiaoLiu
忧心的曼凝
Nina
LaTeXer
dodo
aaa
jyy
bazinga00
COSMAO
比比谁的速度快
核桃
从容芮
pcr163
皖公网安备34019202002308
